Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600120435) titled 'Clinical study of tigilene fumarate combined with remimazolam in day-case hysteroscopic surgery' on March 13.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Liuzhou Maternity and Child Healthcare Hospital
Condition:
General anesthesia medication plan for patients undergoing day surgery with hysteroscopy
Intervention:
Group B (Teglitidine 0.75mg group):Intravenous injection of Tegretol fumarate 0.75 mg
Group C (Alfentanyl Group):Intravenous injection of alfentanil at a dose of 10 µg/kg
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-03-20
T...